Quality of Life 1y and 2 y After VV-ECMO for COVID-19

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

February 1, 2024

Conditions
COVID-19 Acute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation ComplicationQuality of LifeDeath
Interventions
DEVICE

VV-ECMO

veno-venous extracorporeal membrane oxygenation

Trial Locations (1)

9000

Ghent university hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER